The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome.
C C Attkisson, R Zwick
https://pubmed.ncbi.nlm.nih.gov/10259963/Actively Recruiting
Led by Florida State University · Updated on 2026-03-05
388
Participants Needed
3
Research Sites
30 weeks
Total Duration
Researchers are evaluating a computerized Anxiety Sensitivity Treatment CAST compared to a health education control HEC in older adults aged 60 and above with mild cognitive impairment MCI or mild Alzheimers Disease and related dementias ADRD, along with their care partners. The study aims to see if CAST can reduce anxiety and related symptoms in these individuals and lessen the burden on their care partners. It also explores treatment mechanisms using a detailed assessment of anxiety sensitivity and anxiety. Participants join as pairs, each consisting of an older adult with MCImild ADRD and their care partner. After a baseline assessment which includes neuropsychological testing, dyads are randomly assigned to either CAST or HEC. CAST involves two 1-hour sessions of a computerized cognitive behavioral therapy protocol focused on reducing anxiety sensitivity, including interactive features and guided interoceptive exposures. HEC, also computerized and lasting 1 hour, provides education on healthy behaviors with behavior tracking and goal-setting. Both groups complete questionnaires during intervention sessions and ecological momentary assessments EMAs for three separate weeks around the interventions. Participants attend six in-person visits baseline, two intervention sessions, and three follow-ups at 1, 3, and 6 months after treatment. During these visits, they complete cognitive tests and questionnaires. Daily EMAs collected through a smartphone or tablet app track emotional and other factors before, during, and after the interventions. Researchers measure changes in anxiety sensitivity and anxiety from baseline through follow-up, along with care partner burden and other mental health outcomes. The total study duration includes these assessments and monitoring over six months post-intervention.
CONDITIONS
Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
N
Norman B Schmidt, Ph.D.
F
Frederick T Schubert, B.A.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Florida State University
Lead Sponsor
Ohio State University
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Computerized Anxiety Sensitivity Treatment (Behavioral Intervention) | Health Education Control (Behavioral Comparator) | Psychological CBT‑based Treatment (Guideline Context) |
|---|---|---|---|
| What it is | A brief computerized behavioral program targeting anxiety sensitivity delivered to adults with mild cognitive impairment or memory concerns and a care partner dyad | A brief computerized health education presentation on healthy behaviors delivered to dyads as a control comparator | Psychological treatments based on cognitive behavioural therapy (CBT) are recommended non‑pharmacological approaches for anxiety or depression in mild cognitive impairment or dementia |
| Role in trial | Investigational behavioral intervention being evaluated | Active control condition consisting of health education | Represents current guideline‑recommended psychological approach not tested in this trial |
| Primary use | Reduce anxiety sensitivity and anxiety symptoms in adults with MCI or dementia risk | Serve as comparison educational activity unrelated to anxiety‑specific treatment | Alleviate anxiety or depression symptoms via structured psychological therapy |
| How it is given or performed | Delivered via brief computerized sessions involving the patient and care partner | Delivered via brief computer presentation on healthy behaviors | Typically delivered in person or via telehealth using structured CBT sessions adapted for cognitive impairment |
| Evidence status | Effectiveness is under evaluation; trial results are pending | Not intended to treat anxiety; serves as placebo comparator | CBT‑based interventions probably have positive effects on anxiety and depression symptoms in MCI or dementia |
| Important limitations | Trial has not reported results yet; effectiveness and feasibility in target population remain unproven | This control does not represent real-world anxiety treatment and may not reflect usual care | Evidence base for anxiety reduction in MCI/dementia is limited in quantity and quality; more high‑quality trials are needed |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants complete cognitive testing, baseline questionnaires, and receive an introduction to the EMA application.
1 baseline visit (in-person or virtual)
Duration - Approximately 3 weeks
Dyads participate in two 1-hour computerized intervention sessions guided by an interventionist, either receiving the Computerized Anxiety Sensitivity Treatment or Health Education Control. Daily electronic assessments are completed one week before, between, and after the intervention sessions.
2 intervention sessions and daily electronic assessments for 3 weeks
Duration - 6 months
Participants complete cognitive testing and outcome questionnaires at 1, 3, and 6 months after the intervention to assess changes and stability in anxiety and related measures.
3 follow-up visits (1, 3, and 6 months post-intervention)
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
C C Attkisson, R Zwick
https://pubmed.ncbi.nlm.nih.gov/10259963/Steven Taylor, Michael J Zvolensky, Brian J Cox...
https://pubmed.ncbi.nlm.nih.gov/17563199/Michael J Zvolensky, Lorra Garey, Thomas A Fergus...
https://pubmed.ncbi.nlm.nih.gov/30199696/D Watson, L A Clark, A Tellegen
https://pubmed.ncbi.nlm.nih.gov/3397865/D V Sheehan, Y Lecrubier, K H Sheehan...
https://pubmed.ncbi.nlm.nih.gov/9881538/C P Hughes, L Berg, W L Danziger...
https://pubmed.ncbi.nlm.nih.gov/7104545/C Randolph, M C Tierney, E Mohr...
https://pubmed.ncbi.nlm.nih.gov/9845158/Francisco A C Vale, Ari P Balieiro, José Humberto Silva-Filho
https://pubmed.ncbi.nlm.nih.gov/29213800/Mary Jo Kupst, Zeeshan Butt, Catherine M Stoney...
https://pubmed.ncbi.nlm.nih.gov/25577948/Abigail E Markley, Kayley M Stratton, Grace Y Cho...
https://pubmed.ncbi.nlm.nih.gov/40774425/Florida State University
Lead Sponsor
Ohio State University
Collaborating Sponsor